This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1987 Mar;9(3):193-8.

Gyrase-inhibitors impair caffeine elimination in man

A H Staib, S Harder, S Mieke, C Beer, W Stille, P Shah

PMID: 3037212

Gyrase-inhibitors impair caffeine elimination in man

A H Staib et al. Methods Find Exp Clin Pharmacol. 1987 Mar.

. 1987 Mar;9(3):193-8.

Authors

A H Staib, S Harder, S Mieke, C Beer, W Stille, P Shah

PMID: 3037212

No abstract available

PubMed Disclaimer

Similar articles

[Gyrase inhibitors modify metabolising processes in the liver].
Staib AH, Harder S, Papenburg A, Stille W. Staib AH, et al. Dtsch Med Wochenschr. 1987 Oct 30;112(44):1720-1. Dtsch Med Wochenschr. 1987. PMID: 2822371 German. No abstract available.
[Resistance against new gyrase inhibitors--1985/86].
Shah PM, Just G, Weigand G, Stille W. Shah PM, et al. Dtsch Med Wochenschr. 1987 May 29;112(22):903-4. Dtsch Med Wochenschr. 1987. PMID: 3034545 German. No abstract available.
[Gyrase inhibitors can delay caffeine elimination].
Staib AH, Harder S, Mieke S, Beer C, Stille W, Shah PM, Frech K. Staib AH, et al. Dtsch Med Wochenschr. 1986 Sep 26;111(39):1500. Dtsch Med Wochenschr. 1986. PMID: 3463500 Clinical Trial. German. No abstract available.
Interaction between quinolones and caffeine.
Staib AH, Stille W, Dietlein G, Shah PM, Harder S, Mieke S, Beer C. Staib AH, et al. Drugs. 1987;34 Suppl 1:170-4. doi: 10.2165/00003495-198700341-00035. Drugs. 1987. PMID: 3481318 Clinical Trial.
Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions.
Sörgel F, Kinzig M. Sörgel F, et al. Am J Med. 1993 Mar 22;94(3A):56S-69S. Am J Med. 1993. PMID: 8383921 Review.

See all similar articles

Cited by

Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state.
Kinzig-Schippers M, Fuhr U, Cesana M, Müller C, Staib AH, Rietbrock S, Sörgel F. Kinzig-Schippers M, et al. Antimicrob Agents Chemother. 1998 Sep;42(9):2359-64. doi: 10.1128/AAC.42.9.2359. Antimicrob Agents Chemother. 1998. PMID: 9736563 Free PMC article. Clinical Trial.
Clinical pharmacokinetics of ciprofloxacin.
Vance-Bryan K, Guay DR, Rotschafer JC. Vance-Bryan K, et al. Clin Pharmacokinet. 1990 Dec;19(6):434-61. doi: 10.2165/00003088-199019060-00003. Clin Pharmacokinet. 1990. PMID: 2292168 Review.
Fluoroquinolone antimicrobial agents.
Wolfson JS, Hooper DC. Wolfson JS, et al. Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378. Clin Microbiol Rev. 1989. PMID: 2680058 Free PMC article. Review.
No influence of ciprofloxacin on ethanol disposition. A pharmacokinetic-pharmacodynamic interaction study.
Kamali F. Kamali F. Eur J Clin Pharmacol. 1994;47(1):71-4. doi: 10.1007/BF00193482. Eur J Clin Pharmacol. 1994. PMID: 7988628 Clinical Trial.
Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Henwood JM, Monk JP. Henwood JM, et al. Drugs. 1988 Jul;36(1):32-66. doi: 10.2165/00003495-198836010-00004. Drugs. 1988. PMID: 3063494 Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information